2013
DOI: 10.1016/j.jacc.2012.08.1033
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Transvenous Mitral Valve Implantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…1 Most prostheses are implanted via a transapical approach; however, another route to access the degenerated prostheses is through the femoral vein, followed by perforation of the interatrial septum and anterograde valve implantation. 2 Herein we present the first experience with this technique performed in our facilities and for our concern the first in Latin America.…”
Section: Transcatheter Mitral Valve-in-valve Implantation In Patients With Degenerated Bio-prostheses ---Experience Of a Centre In Mexicomentioning
confidence: 95%
See 1 more Smart Citation
“…1 Most prostheses are implanted via a transapical approach; however, another route to access the degenerated prostheses is through the femoral vein, followed by perforation of the interatrial septum and anterograde valve implantation. 2 Herein we present the first experience with this technique performed in our facilities and for our concern the first in Latin America.…”
Section: Transcatheter Mitral Valve-in-valve Implantation In Patients With Degenerated Bio-prostheses ---Experience Of a Centre In Mexicomentioning
confidence: 95%
“…La incidencia de anomalías coronarias es baja en la población general, oscilando entre el 0.46-1.55%, y la agenesia de tronco coronario izquierdo (TCI) es una de las menos observadas 1,2 . Se trata de una entidad extremadamente rara en la que no existe el ostium coronario izquierdo y el TCI termina ciegamente 3 .…”
Section: ¿Dónde Está El Tronco Coronario Izquierdo?unclassified
“…53 The next largest series of 7 TA valve-in-valve implantations for failing mitral bioprosthesis using the 26-or 29-mm SAPIEN valve was reported by Wilbring et al 54 After a mean follow-up of 93 Ϯ 29 days, only one patient had died secondary to a fatal pneumonia.…”
Section: Failing Bioprosthesesmentioning
confidence: 99%